The global market for Ursodeoxycholic Acid API was valued at US$ 556 million in the year 2024 and is projected to reach a revised size of US$ 1006 million by 2031, growing at a CAGR of 8.7% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ursodeoxycholic Acid API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3伪, 7尾-2-hydroxy-5尾-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.
The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) API market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA API as a key component in manufacturing medications to address these conditions.
However, the UDCA API market faces several challenges, with regulatory hurdles and price pressures being significant constraints. The stringent approval requirements and the need for high-quality production standards in API manufacturing can delay the market entry of new players and increase operational costs. Furthermore, with the increasing production of generic UDCA products, competition has intensified, leading to a decrease in profit margins for manufacturers of branded UDCA drugs. Another challenge is the limited scope of UDCA applications, as the drug is effective primarily for a specific set of liver conditions, limiting its broader market appeal. Additionally, supply chain disruptions and raw material price fluctuations for manufacturing UDCA can affect the availability and cost-effectiveness of APIs, further complicating market dynamics.
Global key players of Ursodeoxycholic Acid API include ICE, Daewoong Chemical, PharmaZell GmbH and Zhongshan Bailing, etc. The top four players hold a share about 81%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ursodeoxycholic Acid API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ursodeoxycholic Acid API.
The Ursodeoxycholic Acid API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ursodeoxycholic Acid API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ursodeoxycholic Acid API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
ICE
Zhongshan Bailing
Daewoong Chemical
PharmaZell GmbH
Dipharma Francis
Suzhou Tianlv
Sichuan Xieli
Chuanning Bio
Shilpa medicare
Symbio generics
Arch Pharma
Segment by Type
Chemical Method
Enzyme Method
Segment by Application
Tablets
Capsules
Suspensions
Production by Region
North America
Europe
China
Japan
South Korea
India
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ursodeoxycholic Acid API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ursodeoxycholic Acid API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ursodeoxycholic Acid API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Ursodeoxycholic Acid API Market Overview
1.1 Product Definition
1.2 Ursodeoxycholic Acid API by Type
1.2.1 Global Ursodeoxycholic Acid API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Chemical Method
1.2.3 Enzyme Method
1.3 Ursodeoxycholic Acid API by Application
1.3.1 Global Ursodeoxycholic Acid API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Suspensions
1.4 Global Market Growth Prospects
1.4.1 Global Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Ursodeoxycholic Acid API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Ursodeoxycholic Acid API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Ursodeoxycholic Acid API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ursodeoxycholic Acid API Production Market Share by Manufacturers (2020-2025)
2.2 Global Ursodeoxycholic Acid API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Ursodeoxycholic Acid API, Industry Ranking, 2023 VS 2024
2.4 Global Ursodeoxycholic Acid API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Ursodeoxycholic Acid API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Ursodeoxycholic Acid API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ursodeoxycholic Acid API, Product Offered and Application
2.8 Global Key Manufacturers of Ursodeoxycholic Acid API, Date of Enter into This Industry
2.9 Ursodeoxycholic Acid API Market Competitive Situation and Trends
2.9.1 Ursodeoxycholic Acid API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ursodeoxycholic Acid API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ursodeoxycholic Acid API Production by Region
3.1 Global Ursodeoxycholic Acid API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Ursodeoxycholic Acid API Production Value by Region (2020-2031)
3.2.1 Global Ursodeoxycholic Acid API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Ursodeoxycholic Acid API by Region (2026-2031)
3.3 Global Ursodeoxycholic Acid API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Ursodeoxycholic Acid API Production Volume by Region (2020-2031)
3.4.1 Global Ursodeoxycholic Acid API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Ursodeoxycholic Acid API by Region (2026-2031)
3.5 Global Ursodeoxycholic Acid API Market Price Analysis by Region (2020-2025)
3.6 Global Ursodeoxycholic Acid API Production and Value, Year-over-Year Growth
3.6.1 North America Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.5 South Korea Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.6 India Ursodeoxycholic Acid API Production Value Estimates and Forecasts (2020-2031)
4 Ursodeoxycholic Acid API Consumption by Region
4.1 Global Ursodeoxycholic Acid API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Ursodeoxycholic Acid API Consumption by Region (2020-2031)
4.2.1 Global Ursodeoxycholic Acid API Consumption by Region (2020-2025)
4.2.2 Global Ursodeoxycholic Acid API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Ursodeoxycholic Acid API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Ursodeoxycholic Acid API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ursodeoxycholic Acid API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Ursodeoxycholic Acid API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ursodeoxycholic Acid API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Ursodeoxycholic Acid API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Ursodeoxycholic Acid API Production by Type (2020-2031)
5.1.1 Global Ursodeoxycholic Acid API Production by Type (2020-2025)
5.1.2 Global Ursodeoxycholic Acid API Production by Type (2026-2031)
5.1.3 Global Ursodeoxycholic Acid API Production Market Share by Type (2020-2031)
5.2 Global Ursodeoxycholic Acid API Production Value by Type (2020-2031)
5.2.1 Global Ursodeoxycholic Acid API Production Value by Type (2020-2025)
5.2.2 Global Ursodeoxycholic Acid API Production Value by Type (2026-2031)
5.2.3 Global Ursodeoxycholic Acid API Production Value Market Share by Type (2020-2031)
5.3 Global Ursodeoxycholic Acid API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Ursodeoxycholic Acid API Production by Application (2020-2031)
6.1.1 Global Ursodeoxycholic Acid API Production by Application (2020-2025)
6.1.2 Global Ursodeoxycholic Acid API Production by Application (2026-2031)
6.1.3 Global Ursodeoxycholic Acid API Production Market Share by Application (2020-2031)
6.2 Global Ursodeoxycholic Acid API Production Value by Application (2020-2031)
6.2.1 Global Ursodeoxycholic Acid API Production Value by Application (2020-2025)
6.2.2 Global Ursodeoxycholic Acid API Production Value by Application (2026-2031)
6.2.3 Global Ursodeoxycholic Acid API Production Value Market Share by Application (2020-2031)
6.3 Global Ursodeoxycholic Acid API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 ICE
7.1.1 ICE Ursodeoxycholic Acid API Company Information
7.1.2 ICE Ursodeoxycholic Acid API Product Portfolio
7.1.3 ICE Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 ICE Main Business and Markets Served
7.1.5 ICE Recent Developments/Updates
7.2 Zhongshan Bailing
7.2.1 Zhongshan Bailing Ursodeoxycholic Acid API Company Information
7.2.2 Zhongshan Bailing Ursodeoxycholic Acid API Product Portfolio
7.2.3 Zhongshan Bailing Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Zhongshan Bailing Main Business and Markets Served
7.2.5 Zhongshan Bailing Recent Developments/Updates
7.3 Daewoong Chemical
7.3.1 Daewoong Chemical Ursodeoxycholic Acid API Company Information
7.3.2 Daewoong Chemical Ursodeoxycholic Acid API Product Portfolio
7.3.3 Daewoong Chemical Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Daewoong Chemical Main Business and Markets Served
7.3.5 Daewoong Chemical Recent Developments/Updates
7.4 PharmaZell GmbH
7.4.1 PharmaZell GmbH Ursodeoxycholic Acid API Company Information
7.4.2 PharmaZell GmbH Ursodeoxycholic Acid API Product Portfolio
7.4.3 PharmaZell GmbH Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 PharmaZell GmbH Main Business and Markets Served
7.4.5 PharmaZell GmbH Recent Developments/Updates
7.5 Dipharma Francis
7.5.1 Dipharma Francis Ursodeoxycholic Acid API Company Information
7.5.2 Dipharma Francis Ursodeoxycholic Acid API Product Portfolio
7.5.3 Dipharma Francis Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Dipharma Francis Main Business and Markets Served
7.5.5 Dipharma Francis Recent Developments/Updates
7.6 Suzhou Tianlv
7.6.1 Suzhou Tianlv Ursodeoxycholic Acid API Company Information
7.6.2 Suzhou Tianlv Ursodeoxycholic Acid API Product Portfolio
7.6.3 Suzhou Tianlv Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Suzhou Tianlv Main Business and Markets Served
7.6.5 Suzhou Tianlv Recent Developments/Updates
7.7 Sichuan Xieli
7.7.1 Sichuan Xieli Ursodeoxycholic Acid API Company Information
7.7.2 Sichuan Xieli Ursodeoxycholic Acid API Product Portfolio
7.7.3 Sichuan Xieli Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Sichuan Xieli Main Business and Markets Served
7.7.5 Sichuan Xieli Recent Developments/Updates
7.8 Chuanning Bio
7.8.1 Chuanning Bio Ursodeoxycholic Acid API Company Information
7.8.2 Chuanning Bio Ursodeoxycholic Acid API Product Portfolio
7.8.3 Chuanning Bio Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Chuanning Bio Main Business and Markets Served
7.8.5 Chuanning Bio Recent Developments/Updates
7.9 Shilpa medicare
7.9.1 Shilpa medicare Ursodeoxycholic Acid API Company Information
7.9.2 Shilpa medicare Ursodeoxycholic Acid API Product Portfolio
7.9.3 Shilpa medicare Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Shilpa medicare Main Business and Markets Served
7.9.5 Shilpa medicare Recent Developments/Updates
7.10 Symbio generics
7.10.1 Symbio generics Ursodeoxycholic Acid API Company Information
7.10.2 Symbio generics Ursodeoxycholic Acid API Product Portfolio
7.10.3 Symbio generics Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Symbio generics Main Business and Markets Served
7.10.5 Symbio generics Recent Developments/Updates
7.11 Arch Pharma
7.11.1 Arch Pharma Ursodeoxycholic Acid API Company Information
7.11.2 Arch Pharma Ursodeoxycholic Acid API Product Portfolio
7.11.3 Arch Pharma Ursodeoxycholic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Arch Pharma Main Business and Markets Served
7.11.5 Arch Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ursodeoxycholic Acid API Industry Chain Analysis
8.2 Ursodeoxycholic Acid API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ursodeoxycholic Acid API Production Mode & Process Analysis
8.4 Ursodeoxycholic Acid API Sales and Marketing
8.4.1 Ursodeoxycholic Acid API Sales Channels
8.4.2 Ursodeoxycholic Acid API Distributors
8.5 Ursodeoxycholic Acid API Customer Analysis
9 Ursodeoxycholic Acid API Market Dynamics
9.1 Ursodeoxycholic Acid API Industry Trends
9.2 Ursodeoxycholic Acid API Market Drivers
9.3 Ursodeoxycholic Acid API Market Challenges
9.4 Ursodeoxycholic Acid API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
ICE
Zhongshan Bailing
Daewoong Chemical
PharmaZell GmbH
Dipharma Francis
Suzhou Tianlv
Sichuan Xieli
Chuanning Bio
Shilpa medicare
Symbio generics
Arch Pharma
听
听
*If Applicable.
